Why Reducing Low-Value Care Fails to Bend the Cost Curve, and Why We Should Do it Anyway

Document Type : Viewpoint


Radboud University Medical Center, Radboud Institute for Health Sciences, IQ healthcare, Nijmegen, The Netherlands



Low-value care provides either a modest benefit or even no benefit at all to the patient, while it is potentially harmful, may not reflect patient preferences, and may result in considerable costs. Several US studies have estimated the nationwide costs of medical waste, including low-value care, at hundreds of billions of dollars.1,2 Health systems can reduce low-value care by targeted de-implementation interventions, of which many have been proven successful.3,4 Studies into de-implementation regularly estimate substantial cost savings to the health system, claiming it will save society millions of dollars. ...(Read more...)

  1. Berwick DM, Hackbarth AD. Eliminating waste in US health care. JAMA. 2012;307(14):1513-1516. doi:1001/jama.2012.362
  2. Shrank WH, Rogstad TL, Parekh N. Waste in the US health care system: estimated costs and potential for savings. JAMA. 2019;322(15):1501-1509. doi:1001/jama.2019.13978
  3. Kroon D, Steutel NF, Vermeulen H, et al. Effectiveness of interventions aiming to reduce inappropriate drug prescribing: an overview of interventions. J Pharm Health Serv Res. 2021;12(3):423-433. doi:1093/jphsr/rmab038
  4. Takada T, Heus P, van Doorn S, et al. Strategies to reduce the use of low-value medical tests in primary care: a systematic review. Br J Gen Pract. 2020;70(701):e858-e865. doi:3399/bjgp20X713693
  5. Naugler C, Hemmelgarn B, Quan H, et al. Implementation of an intervention to reduce population-based screening for vitamin D deficiency: a cross-sectional study. CMAJ Open. 2017;5(1):E36-E39. doi:9778/cmajo.20160073
  6. Bindraban RS, van Beneden M, Kramer MHH, et al. Association of a multifaceted intervention with ordering of unnecessary laboratory tests among caregivers in internal medicine departments. JAMA Netw Open. 2019;2(7):e197577. doi:1001/jamanetworkopen.2019.7577
  7. Flaherty S, Zepeda ED, Mortele K, Young GJ. Magnitude and financial implications of inappropriate diagnostic imaging for three common clinical conditions. Int J Qual Health Care. 2019;31(9):691-697. doi:1093/intqhc/mzy248
  8. Malik HT, Marti J, Darzi A, Mossialos E. Savings from reducing low-value general surgical interventions. Br J Surg. 2018;105(1):13-25. doi:1002/bjs.10719
  9. Delamater PL, Messina JP, Grady SC, WinklerPrins V, Shortridge AM. Do more hospital beds lead to higher hospitalization rates? a spatial examination of Roemer's law. PLoS One. 2013;8(2):e54900. doi:1371/journal.pone.0054900
  10. Hensher M, Tisdell J, Zimitat C. "Too much medicine": insights and explanations from economic theory and research. Soc Sci Med. 2017;176:77-84. doi:1016/j.socscimed.2017.01.020
  11. Wackers E, van Dulmen S, Berden B, Kremer J, Stadhouders N, Jeurissen P. Improving performance in complex surroundings: a mixed methods evaluation of two hospital strategies in the Netherlands. Int J Health Policy Manag. 2023. doi:34172/ijhpm.2023.7243
  12. Wammes JJG, Frederix G, Govaert P, et al. Case-studies of displacement effects in Dutch hospital care. BMC Health Serv Res. 2020;20(1):263. doi:1186/s12913-020-05086-9
  13. Rauh SS, Wadsworth EB, Weeks WB, Weinstein JN. The savings illusion--why clinical quality improvement fails to deliver bottom-line results. N Engl J Med. 2011;365(26):e48. doi:1056/NEJMp1111662
  14. Roberts RR, Frutos PW, Ciavarella GG, et al. Distribution of variable vs fixed costs of hospital care. JAMA. 1999;281(7):644-649. doi:1001/jama.281.7.644
  15. van Dulmen SA, Stadhouders N, Westert G, Wackers E, Jeurissen P. Op weg naar hoge kwaliteit en lage kosten in de medisch specialistische zorg. Rapport evaluatie veranderprogramma’s Rivas Zorggroep en Bernhoven. Nijmegen: IQ healthcare; 2020.
  16. Hofmann B. Internal barriers to efficiency: why disinvestments are so difficult. Identifying and addressing internal barriers to disinvestment of health technologies. Health Econ Policy Law. 2021;16(4):473-488. doi:1017/s1744133121000037
  17. McWilliams JM, Hatfield LA, Landon BE, Hamed P, Chernew ME. Medicare spending after 3 years of the Medicare Shared Savings Program. N Engl J Med. 2018;379(12):1139-1149. doi:1056/NEJMsa1803388
  18. Vlaanderen FP, Tanke MA, Bloem BR, et al. Design and effects of outcome-based payment models in healthcare: a systematic review. Eur J Health Econ. 2019;20(2):217-232. doi:1007/s10198-018-0989-8
  19. Zorginstituut Nederland (ZIN). Zinnige Zorg - Verbetersignalement Maagklachten. https://www.zorginstituutnederland.nl/publicaties/rapport/2021/07/13/zinnige-zorg-verbetersignalement-maagklachten.
  20. Crisp N, Chen L. Global supply of health professionals. N Engl J Med. 2014;370(10):950-957. doi:1056/NEJMra1111610
  21. Wetenschappelijke Raad voor het Regeringsbeleid (WRR). Kiezen voor houdbare zorg. Mensen, middelen en maat schappelijk draagvlak. wrr-Rapport 104. Den Haag: WRR; 2021. https://www.wrr.nl/publicaties/rapporten/2021/09/15/kiezen-voor-houdbare-zorg.